ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 393

$830K Total Retail Price of All Prescriptions

Rank: 10 out of 393

1,363 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,363 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 1,363 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 19,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,203 1,097 1 2
LEVOTHYROXINE SODIUM 1,167 1,090 2 3
SIMVASTATIN 1,035 921 3 1
HYDROCODONE-ACETAMINOPHEN 891 736 S3 4 5
OMEPRAZOLE 827 770 5 6
AMLODIPINE BESYLATE 650 621 6 4
METFORMIN HCL 598 528 7 7
ALENDRONATE SODIUM 528 494 8 16
ZOLPIDEM TARTRATE 452 409 9 11
PRAVASTATIN SODIUM 438 388 10 18
HYDROCHLOROTHIAZIDE 368 336 11 10
LOSARTAN POTASSIUM 357 329 12 12
GABAPENTIN 325 295 13 15
LOVASTATIN 317 311 14 14
FINASTERIDE 302 301 15 60
METOPROLOL TARTRATE 294 283 16 9
ATENOLOL 293 284 17 13
SPIRIVA 273 241 18 41
WARFARIN SODIUM 269 244 19 17
VENTOLIN HFA 264 238 20 42
FENOFIBRATE 258 238 21 43
FUROSEMIDE 245 228 22 8
TAMSULOSIN HCL 236 231 23 25
POTASSIUM CHLORIDE 230 217 24 20
ALLOPURINOL 230 224 24 26
METOPROLOL SUCCINATE 217 193 26 22
CITALOPRAM HBR 216 186 27 23
TERAZOSIN HCL 210 210 28 38
ATORVASTATIN CALCIUM 205 173 29 19
CARVEDILOL 192 178 30 21
FLUTICASONE PROPIONATE 182 160 31 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 164 32 24
ACTOS 172 159 33 78
LOSARTAN-HYDROCHLOROTHIAZIDE 163 157 34 31
BACLOFEN 160 143 35 79
PREDNISONE 153 133 36 65
ETODOLAC 152 137 37 165
OXYBUTYNIN CHLORIDE 148 141 38 90
CLOPIDOGREL 135 128 39 33
GLIMEPIRIDE 134 120 40 39
GLYBURIDE 130 116 R 41 46
POLYETHYLENE GLYCOL 3350 127 124 42 99
MORPHINE SULFATE ER 126 78 S2 43 48
PLAVIX 114 109 44 51
OXYCODONE HCL 113 57 S2 45 36
OXYCODONE HCL-ACETAMINOPHEN 109 73 S2 46 54
TRAZODONE HCL 107 88 47 47
SYMBICORT 106 101 48 96
BENAZEPRIL HCL 105 105 49 40
DONEPEZIL HCL 104 103 50 34
GLIPIZIDE 100 92 51 32
SERTRALINE HCL 95 57 52 28
TRICOR 95 74 52 128
FLUOXETINE HCL 90 42 54 37
DIGOXIN 90 77 54 66
IBUPROFEN 90 77 54 55
ROPINIROLE HCL 88 83 57 121
NIFEDIPINE ER 87 87 58 91
RANITIDINE HCL 85 85 59 29
CARISOPRODOL 84 28 R 60 45
TRAMADOL HCL 81 79 61 30
NAPROXEN 80 75 62 85
LANTUS SOLOSTAR 79 74 63 74
GEMFIBROZIL 75 68 64 62
AZITHROMYCIN 75 55 64 35
LANTUS 74 62 66 73
PIOGLITAZONE HCL 72 61 R 67 173
ACYCLOVIR 67 66 68 219
QVAR 65 62 69 101
METFORMIN HCL ER 63 57 70 63
PEN NEEDLE 61 55 71 81
THEOPHYLLINE ANHYDROUS 60 43 72 204
ISOSORBIDE MONONITRATE ER 59 58 73 67
KLOR-CON 10 59 49 73 113
MUPIROCIN 58 57 75 184
INSULIN SYRINGE 58 52 75 110
CLOTRIMAZOLE-BETAMETHASONE 57 50 77 156
CIPROFLOXACIN HCL 57 50 77 57
AMITRIPTYLINE HCL 54 39 R 79 72
HYDRALAZINE HCL 54 52 79 64
DILTIAZEM ER 51 50 81 107
TRIAMCINOLONE ACETONIDE 51 42 81 94
KLOR-CON M10 50 50 83 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.